The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Adda Nathalie since 2018.
This trader's CIK number is 1646976.
At the time of last reporting, Adda Nathalie was the Sr. VP & Chief Medical Officer of Enanta Pharmaceuticals Inc. (stock ticker symbol ENTA).
Also see all insider trading activities at Enanta Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | ENTA | 0 | $0 | 132,700 | $9,428,249 | 132,700 | $5,612,167 |
| 2021 | ENTA | 0 | $0 | 40,570 | $3,223,432 | 40,570 | $1,845,691 |
| 2020 | ENTA | 0 | $0 | 0 | $0 | 10,500 | $0 |
| 2018 | ENTA | 0 | $0 | 25,890 | $2,681,423 | 17,730 | $770,544 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-04-01 | ENTA | Option Ex | 50,559 | 36.65 | 1,852,835 |
| 2022-04-01 | ENTA | Sale | 50,559 | 71.03 | 3,591,458 |
| 2022-04-04 | ENTA | Option Ex | 32,785 | 51.81 | 1,698,689 |
| 2022-04-04 | ENTA | Sale | 32,785 | 72.08 | 2,363,306 |
| 2022-03-02 | ENTA | Sale | 12,481 | 70.07 | 874,543 |
| 2022-03-01 | ENTA | Option Ex | 24,339 | 43.46 | 1,057,772 |
| 2022-03-02 | ENTA | Option Ex | 12,481 | 43.46 | 542,424 |
| 2022-03-01 | ENTA | Sale | 24,339 | 70.66 | 1,719,793 |
| 2022-01-11 | ENTA | Sale | 12,536 | 70.13 | 879,149 |
| 2022-01-11 | ENTA | Option Ex | 12,536 | 36.73 | 460,447 |
| 2021-12-01 | ENTA | Option Ex | 13,523 | 45.99 | 621,922 |
| 2021-12-01 | ENTA | Sale | 13,523 | 87.45 | 1,182,599 |
| 2021-11-01 | ENTA | Sale | 9,547 | 85.18 | 813,213 |
| 2021-11-01 | ENTA | Option Ex | 9,547 | 48.52 | 463,220 |
| 2021-10-08 | ENTA | Option Ex | 13,453 | 43.46 | 584,667 |
| 2021-10-08 | ENTA | Sale | 13,453 | 70.09 | 942,934 |
| 2021-10-11 | ENTA | Option Ex | 4,047 | 43.46 | 175,882 |
| 2021-10-11 | ENTA | Sale | 4,047 | 70.34 | 284,686 |
| 2020-12-15 | ENTA | Option Ex | 5,250 | .00 | 0 |
| 2019-12-16 | ENTA | Option Ex | 5,250 | .00 | 0 |
| 2018-09-20 | ENTA | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-09-20 | ENTA | Sale | 4,155 | 94.88 | 394,230 |
| 2018-08-20 | ENTA | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-08-20 | ENTA | Sale | 4,155 | 92.06 | 382,517 |
| 2018-07-18 | ENTA | Sale | 5,045 | 124.98 | 630,519 |
| 2018-07-18 | ENTA | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-06-18 | ENTA | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-06-18 | ENTA | Sale | 4,155 | 114.96 | 477,658 |
| 2018-05-16 | ENTA | Sale | 4,155 | 104.74 | 435,190 |
| 2018-05-16 | ENTA | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-04-16 | ENTA | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-04-16 | ENTA | Sale | 4,225 | 85.52 | 361,309 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Adda Nathalie (Sr. VP & Chief Medical Officer of Enanta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.